Please login to the form below

Not currently logged in
Email:
Password:

Pfizer resurrects its OTC bid for Viagra in the UK

Confirms MHRA review of new pharmacist-supplied status has begun

Pfizer

Nearly nine years after its last attempt to make its blockbuster erectile dysfunction treatment available without a prescription, Pfizer is having another go.

UK regulator the MHRA has began reviewing an application to allow Viagra (sildenafil) to be made available without a prescription if supplied by a pharmacist - a move that would grant it ‘P’, though not OTC (over-the-counter), status.

If approved, Pfizer’s plans would see it continue to market the medicine as a prescription-only treatment under the Viagra brand and then it would provide pharmacists with training on dispensing sildenafil at a 50mg dose.

Pfizer’s UK medical director Dr Berkeley Phillips said: “The availability of pharmacist-supplied, non-prescription sildenafil could offer men a new and additional way to access a legitimate, long established, and well-studied treatment for erectile dysfunction.

“This could have further benefits as the condition may be an early warning sign of a more serious underlying condition, such as heart disease4, which may otherwise go undetected.”

Pfizer has previously tried for European approval to make Viagra available without a prescription, but those plans were scuppered in 2008 after regulatory advisors voiced concerns about misuse of the drug.

Article by
Dominic Tyer

28th March 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics